Up-regulation of aldose reductase by the substrate, methylglyoxal

Chemico-Biological Interactions

Volumn 143-144, Issue , 2003, Pages 317-323

  Yabe Nishimura, Chihiro ^a   Nishinaka, Toru ^a   Iwata, Kazumi ^a   Seo, Han Geuk ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Aldose reductase; Methylglyoxal; Reactive oxygen species; Vascular smooth muscle cells

Indexed keywords

ACETOACETIC ACID DERIVATIVE; ACETYLCYSTEINE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; BUTHIONINE SULFOXIMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCEIN DERIVATIVE; HYDROGEN PEROXIDE; MESSENGER RNA; METHYLGLYOXAL; MITOGEN ACTIVATED PROTEIN KINASE; PONALRESTAT; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA; CELL CULTURE; CELL DAMAGE; CELL ISOLATION; CELL LEVEL; CELL PROTECTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALDEHYDE REDUCTASE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; MUSCLE, SMOOTH, VASCULAR; PYRUVALDEHYDE; RATS; RNA, MESSENGER; SUBSTRATE SPECIFICITY; UP-REGULATION;

EID: 0037330333     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00189-8     Document Type: Conference Paper

References (11)

1. McLellan A.C., Thornalley P.J., Benn J., Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 87:1994;21-29.
2. Vander Jagt D.L., Robinson B., Taylor K.K., Hunsaker L.A. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267:1992;4364-4369.
3. Nishimura C., Graham C., Hohman T.C., Nagata M., Robison W.G. Jr., Carper D. Characterization of mRNA and genes for aldose reductase in rat. Biochem. Biophys. Res. Commun. 153:1988;1051-1059.
4. Nishimura C., Furue M., Ito T., Omori Y., Tanimoto T. Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase. Biochem. Pharmacol. 46:1993;21-28.
5. Gui T., Tanimoto T., Kokai Y., Nishimura C. Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse. Eur. J. Biochem. 227:1995;448-453.
6. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50:1998;21-33.
7. Seo H.G., Nishinaka T., Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol. Pharmacol. 57:2000;709-717.
8. Chang K.C., Paek K.S., Kim H.J., Lee Y.S., Yabe-Nishimura C., Seo H.G. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol. Pharmacol. 61:2002;1184-1191.
9. Nishinaka T., Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates up-regulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 31:2001;205-216.
10. Chaplen F.W., Fahl W.E., Cameron D.C. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 95:1998;5533-5538.
11. Spycher S.E., Tabataba-Vakili S., O'Donnell V.B., Palomba L., Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J. 11:1997;181-188.